Abstract | PURPOSE OF REVIEW: Treatment options for mitochondrial myopathies remain limited despite rapid advances in the understanding of the molecular basis of these conditions. Existing therapies continue to be evaluated and novel treatment strategies are starting to appear on the horizon. RECENT FINDINGS: SUMMARY:
|
Authors | Adam Hassani, Rita Horvath, Patrick F Chinnery |
Journal | Current opinion in neurology
(Curr Opin Neurol)
Vol. 23
Issue 5
Pg. 459-65
(Oct 2010)
ISSN: 1473-6551 [Electronic] England |
PMID | 20651591
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- PPAR gamma
- Vitamins
- Ubiquinone
- coenzyme Q10
|
Topics |
- Animals
- Diet, Ketogenic
- Dietary Supplements
- Exercise Therapy
- Humans
- Mitochondrial Myopathies
(genetics, pathology, physiopathology, therapy)
- Mutation
- PPAR gamma
(metabolism)
- Ubiquinone
(analogs & derivatives, therapeutic use)
- Vitamins
(therapeutic use)
|